Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A W Harman

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Toxicology Letters|December 1, 1992
Protection from oxidative damage in mouse liver cellsA W Harman, G M Adamson, S G Shaw
British Journal of Industrial Medicine|February 1, 1981
Induction of microsomal drug metabolism in man and in the rat by exposure to petroleumA W Harman, D B Frewin, B G Priestly
Biochemical and Biophysical Research Communications|July 31, 1990
Cytosolic free magnesium, ATP and blebbing during chemical hypoxia in cultured rat hepatocytesA W Harman, A L Nieminen, J J Lemasters, et al.
Clinical and Experimental Neurology|January 1, 1979
Antiopyrine half-life as a measure of hepatic enzyme induction: clinical applications in a chronic epileptic populationE Byrne, A W Harman, D B Frewin, et al.
Biochemical Pharmacology|April 15, 1991
The killing of cultured hepatocytes by N-acetyl-p-benzoquinone imine (NAPQI) as a model of the cytotoxicity of acetaminophenA W Harman, M E Kyle, A Serroni, et al.
Molecular Pharmacology|April 1, 1992
Level of cytosolic free calcium during acetaminophen toxicity in mouse hepatocytesA W Harman, S O Mahar, P C Burcham, et al.
British Journal of Clinical Pharmacology|January 1, 1979
Impairment of hepatic drug metabolism in alcoholicsA W Harman, D B Frewin, B G Priestly, et al.
Anaesthesia and Intensive Care|August 1, 1978
Altered drug metabolism in anaesthetists exposed to volatile anaesthetic agentsA W Harman, W J Russell, D B Frewin, et al.
Australian and New Zealand Journal of Medicine|August 1, 1977
Salivary antipyrine kinetics in hepatic and renal disease and in patients on anticonvulsant therapyA W Harman, R K Penhall, B G Priestly, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Toxicology Letters|December 1, 1992
Protection from oxidative damage in mouse liver cellsA W Harman, G M Adamson, S G Shaw
British Journal of Industrial Medicine|February 1, 1981
Induction of microsomal drug metabolism in man and in the rat by exposure to petroleumA W Harman, D B Frewin, B G Priestly
Biochemical and Biophysical Research Communications|July 31, 1990
Cytosolic free magnesium, ATP and blebbing during chemical hypoxia in cultured rat hepatocytesA W Harman, A L Nieminen, J J Lemasters, et al.
Clinical and Experimental Neurology|January 1, 1979
Antiopyrine half-life as a measure of hepatic enzyme induction: clinical applications in a chronic epileptic populationE Byrne, A W Harman, D B Frewin, et al.
Biochemical Pharmacology|April 15, 1991
The killing of cultured hepatocytes by N-acetyl-p-benzoquinone imine (NAPQI) as a model of the cytotoxicity of acetaminophenA W Harman, M E Kyle, A Serroni, et al.
Molecular Pharmacology|April 1, 1992
Level of cytosolic free calcium during acetaminophen toxicity in mouse hepatocytesA W Harman, S O Mahar, P C Burcham, et al.
British Journal of Clinical Pharmacology|January 1, 1979
Impairment of hepatic drug metabolism in alcoholicsA W Harman, D B Frewin, B G Priestly, et al.
Anaesthesia and Intensive Care|August 1, 1978
Altered drug metabolism in anaesthetists exposed to volatile anaesthetic agentsA W Harman, W J Russell, D B Frewin, et al.
Australian and New Zealand Journal of Medicine|August 1, 1977
Salivary antipyrine kinetics in hepatic and renal disease and in patients on anticonvulsant therapyA W Harman, R K Penhall, B G Priestly, et al.
Pageof 3